Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiolog... (a Accessed on: January 28 2009. .....)

Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiology Congress

Date:8/25/2009

a> Accessed on: January 28, 2009.

(5) Eriksson BI, et al. "Dabigatran Etexilate Versus Enoxaparin for Prevention of Venous Thromboembolism after Total Hip Replacement: A Randomized, Double-Blind, Non-Inferiority Trial." The Lancet. 2007; 370:949-956.

(6) The RE-MOBILIZE Writing Committee. "Oral Thrombin Inhibitor Dabigatran Etexilate vs North American Enoxaprin Regimen for Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery." The Journal of Arthroplasty. 2009; 24:1-9.

(7) ClinicalTrials.gov. "A Phase III Randomised, Parallel Group, Double-Blind, Active Controlled Study to Investigate the Efficacy and Safety of Orally Administered 220 mg Dabigatran Etexilate Capsules (110 mg Administered on the Day of Surgery Followed by 220 mg Once Daily) Compared to Subcutaneous 40 mg Enoxaparin Once Daily for 28-35 Days, in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip Arthroplasty Surgery. (RE-NOVATE II)." Available at: http://www.clinicaltrials.gov/ct2/show/NCT00657150?term=dabogatran&rank=7. Accessed on: January 28, 2009.

(8) ClinicalTrials.gov. "A Randomised, Multicenter, Double-Blind, Active Controlled Study to Investigate the Efficacy and Safety of Dabigatran Etexilate, 150 mg b.i.d Administered Orally (Capsules) for 18 Months, Compared to Warfarin Tablets p.r.n. (Target INR) for the Secondary Prevention of Venous Thromboembolism." Available at: http://www.clinicaltrials.gov/ct2/show/NCT00329238?term=dabigatran&rank=12. Accessed on: January 28, 2009.

(9) ClinicalTrials.gov. "A Phase III, Randomised, Double Blind, Parallel-Group St
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7
Related medicine technology :

1. CTMM Becomes One of the Worlds Largest Public-Private Partnerships in Translational Medical Research
2. PSA Screening Cuts Deaths by 20%, Says Worlds Largest Prostate Cancer Study
3. Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer
4. Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series
5. Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD
6. The Largest Ever Study of Diabetes Shows Intensive Glucose Control Reduces Serious Complications
7. Safety and Efficacy Results Presented From Largest Prospective Controlled Clinical Study of Ulcerative Colitis
8. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
9. Universite de Montreal Researchers Simulate Worlds Largest Heart Model Using SGI Technology
10. Video: New Results From One of the Worlds Largest Breast Cancer Trials Herald Hope for Thousands of Women
11. Raydiance Collaborates With Rutgers University and Nations Largest Tissue Bank to Develop Innovative Tissue Processing Approaches

Post Your Comments:

(Date:6/18/2013)... YORK, Pa. , June 18, 2013 ... a U.S. based designer, developer and manufacturer of injectable ... new corporate website at www.unilife.com . The new ... information, with updates to occur on a regular basis. ... of Unilife, stated, "As an emerging global leader for ...

(Date:6/18/2013)... 2013 In a letter to authorities at her hospital, ... Lake View, Iowa , writes that a policy ... is neither scientifically justified nor ethically sound. Her ... summer issue of the Journal of American Physicians and ... and an average of 36,000 patients per year die in ...

(Date:6/18/2013)... -- The board of directors of Eli Lilly and ... dividend for the third quarter of 2013 of $0.49 ... The dividend is payable September 10, 2013 to shareholders ... 15, 2013. Lilly, a leading innovation-driven corporation, ... applying the latest research from its own worldwide laboratories ...

Breaking Medicine Technology:Unilife Launches New Corporate Website 2 Mandated Flu Vaccine for Hospital Workers Ethically Questionable, Surgeon Writes 2

[0] Unilife Launches New Corporate Website [0] Mandated Flu Vaccine for Hospital Workers Ethically Questionable, Surgeon Writes [0] Lilly Declares Third-Quarter 2013 Dividend

... March 15, 2011 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ... ), a leading fully integrated pharmaceutical company producing over-the-counter drugs ... results for the fourth quarter and fiscal year ended December ... uarter 2010 Highlights Total revenues ...

... PDI, Inc. (Nasdaq: PDII ), ... to established and emerging health care companies, today announced ... the leading provider of advanced analytics and predictive modeling ... this agreement, PDI will gain access for its pharmaceutical ...

China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results PDI Announces Exclusive Partnership With Qforma, Leading Provider of Advanced Analytics for Health Sciences Industry

(Date:6/18/2013)... 18, 2013 -- Lauren Sciences, a privately-held biotechnology ... platform technology, announced today that it was independently ... with its V-Smart Platform, and selected as a ... Group. , The report, " Early ... Emerging Companies ," features companies MCD Group independently ...

(Date:6/18/2013)... are more likely to keep their scheduled medical appointments ... feel their physician listens, explains things clearly and knows ... Johns Hopkins research suggests. , "If people feel their ... feel that doctor has their best interests at heart ... says study leader Tabor E. Flickinger, M.D., M.P.H., a ...

(Date:6/18/2013)... Obama officially declared June as Lesbian, Gay, ... despite advances in civil rights, sexual minority ... suicide than their heterosexual peers, according to ... of Missouri psychology graduate student recently published ... minority youth, which could help improve psychological ...

(Date:6/18/2013)... FDA to support the need for a blood test ... University of Rochester Medical Center just added significant evidence ... that it might be clinically useful to measure two ... M.P.H., an associate professor of Emergency Medicine at URMC, ... combination of two proteins released into the bloodstream after ...

(Date:6/18/2013)... penalties on hospitals with higher-than-expected rates of 30-day ... are evaluating the most accurate methods for tracking ... in the June issue of the Journal ... that the American College of Surgeons National Surgical ... accurate data tracking than another popular database, the ...

Breaking Medicine News(10 mins):Health News:Respect may be the key to stopping patient 'no shows' 2 Health News:Sexual minority youth need specialized treatment from therapists 2 Health News:ACS NSQIP® data is more accurate than administrative data for tracking 30-day hospital readmissions 2 Health News:ACS NSQIP® data is more accurate than administrative data for tracking 30-day hospital readmissions 3 Health News:ACS NSQIP® data is more accurate than administrative data for tracking 30-day hospital readmissions 4

[0] Lauren Sciences independently recognized as a Technology Innovator in Drug Delivery with its V-Smart™ Platform, and selected as a Featured Company, in new report by MCD Group [0] Respect may be the key to stopping patient 'no shows'[0] Sexual minority youth need specialized treatment from therapists [0] New concussion data: 2 biomarkers better than 1 [0] ACS NSQIP® data is more accurate than administrative data for tracking 30-day hospital readmissions

... a milestone in the evolution of its pioneering stem ... received a $34.9 million grant from the California Institute ... a regenerative medicine building on its campus. , The ... Rafael Violy, was approved by the UC Regents in ...

... project as innovative in terms of energy efficiency and ... awarded nearly $27 million in funding for a new ... (USC). USC was one of 12 California institutions considered ... million to build stem cell research facilities throughout California. ...

... The University of Alabama at Birmingham (UAB) this ... a speedier cancer radiation therapy. The new technique can ... for selected patients. , Additionally, the new therapy saves ... that are the same or better than other radiotherapy ...

... SAN CARLOS, Calif., May 7 Nektar Therapeutics,(Nasdaq: NKTR ... ended March 31, 2008., Cash, cash equivalents, and short-term ... million at December 31, 2007., Nektar reported a net ... quarter of 2008, compared to a net loss of $25.7 ...

... PHILADELPHIA, May 7 Kappa Alpha Psi Fraternity, Inc.,announced ... the St.,Jude Children,s Research Hospital and their work to ... the St. Jude Children,s Research,Hospital in Memphis, TN, May ... Fraternity, Inc., has taken on the,awesome responsibility of sponsoring ...

... 7 /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals,a developer and manufacturer ... announced the appointment of David B. Holtz as ... 2008. In these,roles, Mr. Holtz will be responsible ... and Information Technology reporting to,Thomas E. Gardner, Chairman ...

Cached Medicine News:Health News:UCSF receives funding for building from California stem cell agency 2 Health News:UCSF receives funding for building from California stem cell agency 3 Health News:USC receives nearly $27 million in funding for new stem cell research facility 2 Health News:UAB first in US to offer speedier precise cancer radiotherapy 2 Health News:Nektar Therapeutics Announces First Quarter 2008 Results 2 Health News:Nektar Therapeutics Announces First Quarter 2008 Results 3 Health News:Nektar Therapeutics Announces First Quarter 2008 Results 4 Health News:Nektar Therapeutics Announces First Quarter 2008 Results 5 Health News:Nektar Therapeutics Announces First Quarter 2008 Results 6 Health News:Nektar Therapeutics Announces First Quarter 2008 Results 7 Health News:Nektar Therapeutics Announces First Quarter 2008 Results 8 Health News:Kappa Alpha Psi Fraternity Celebrates St. Jude Partnership 2 Health News:Kappa Alpha Psi Fraternity Celebrates St. Jude Partnership 3 Health News:NUCRYST Appoints David B. Holtz as Vice President and Chief Financial Officer 2 Health News:NUCRYST Appoints David B. Holtz as Vice President and Chief Financial Officer 3 Health News:NUCRYST Appoints David B. Holtz as Vice President and Chief Financial Officer 4

UCSF receives funding for building from California stem cell agency USC receives nearly $27 million in funding for new stem cell research facility UAB first in US to offer speedier precise cancer radiotherapy Nektar Therapeutics Announces First Quarter 2008 Results Kappa Alpha Psi Fraternity Celebrates St. Jude Partnership NUCRYST Appoints David B. Holtz as Vice President and Chief Financial Officer

The Linvatec 3mm and 5mm Universal Light Guides are autoclavable. They offer flexibility, superior light transmission, and universal fittings in a lightweight package....

ACMI™ offers an assortment of fiberoptic light guides, high transmission autoclavable fiberoptic light guides, and light guide adapters to connect our scopes to other manufacturers' light sourc...

... EndoEYE offers a revolutionary ... places a miniaturized CCD chip ... making fragile rod lenses a ... puts your eye right at ...

Medicine Products:

5mm Universal Light Guide High Transmission Autoclavable Fiberoptic Light Guide, with 45 angled instrument fitting, snap-on Fiberoptic Light Guide, snap-on EndoEYE Surgical Videoscopes